Toggle search
Toggle menu
413
29
47
7.6K
Pharmacopedia
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

User contributions for MDElliottMD

More actions
Results for MDElliottMD talk block log uploads logs abuse log
A user with 5,667 edits. Account created on 9 May 2026.
Pharmacopedia
BrowseCategoriesLog in
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

21 May 2026

20 May 2026

  • 23:2123:21, 20 May 2026 diff hist −115 Fluoxetine Removed problem "ref-embarrassment" (admin removal)
  • 20:2020:20, 20 May 2026 diff hist −64 Template:MedTemplate WCAG S1: MedTemplate section labels are now real <h2>/<h3> headings
  • 20:2020:20, 20 May 2026 diff hist −32 Main Page WCAG S1: Main Page module labels are now real <h2> headings
  • 20:1420:14, 20 May 2026 diff hist +33 Bupropion No edit summary Tag: 2017 source edit
  • 18:5518:55, 20 May 2026 diff hist +1,303 Category:Pharmacogenomic phenotypes Add CYP3A4 to the indexed phenotype list (3 pages: PM/IM/NM) and add a lead paragraph on the CPIC/DPWG disagreement over whether CYP3A4 warrants a phenotype scheme. Per parser-claude 2026-05-20 source check confirming the DPWG CYP3A4 framework is valid. Category now indexes 29 phenotype pages across 8 genes.
  • 18:5518:55, 20 May 2026 diff hist +1,226 Enzyme:CYP3A4 Revise CYP3A4 Phenotype categories section per parser-claude 2026-05-20: the earlier text flatly stated CYP3A4 has no metabolizer-phenotype classification. That is true for CPIC but not for DPWG, which tiers CYP3A4 into PM/IM/NM on the CYP3A4*22 allele. New text states the CPIC/DPWG disagreement, links the three Phenotype:CYP3A4 pages, and keeps the point that environmental induction/inhibition dominate CYP3A4 variability. Cites DPWG guideline PharmGKB PA166265421. See-also gains the three ph...
  • 18:5518:55, 20 May 2026 diff hist +3,601 N Phenotype:CYP3A4 normal metabolizer Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.
  • 18:5518:55, 20 May 2026 diff hist +3,571 N Phenotype:CYP3A4 intermediate metabolizer Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.
  • 18:5518:55, 20 May 2026 diff hist +4,489 N Phenotype:CYP3A4 poor metabolizer Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.
  • 04:5904:59, 20 May 2026 diff hist 0 Fluoxetine Fix malformed self-closing <ref> tag (resolves the pk_elimination cite error)
  • 04:2804:28, 20 May 2026 diff hist +3,422 Main Page C/Specimen redesign: Main Page module grid
  • 04:2804:28, 20 May 2026 diff hist +1,253 Template:MedTemplate C/Specimen redesign: medicine-page template (title block, datasheet rail, numbered sections)
  • 03:4003:40, 20 May 2026 diff hist +42 N ASRS-v1.1 Redirect to Adult ADHD Self-Report Scale current Tag: New redirect
  • 03:4003:40, 20 May 2026 diff hist +42 N ASRS Redirect to Adult ADHD Self-Report Scale current Tag: New redirect
  • 03:2603:26, 20 May 2026 diff hist +7,009 N Adult ADHD Self-Report Scale Create encyclopedic page for the ASRS-v1.1 (Adult ADHD Self-Report Scale): development under the WHO (Kessler, Harvard; Adler, NYU), structure (18-item checklist + 6-item Screener), threshold scoring, validation, the DSM-5 update, wiki use as the validated companion to AMAAS, and the NYU/Harvard licensing + mandatory attribution notice. Citations Kessler 2005 PMID 15841682, Kessler 2007 PMID 17623385, Ustun 2017 PMID 28384801, all NCBI-eutils-verified. Describes the instrument; reproduces no... current
  • 00:3200:32, 20 May 2026 diff hist +10,539 N Category:Pharmacogenomic phenotypes Create Category:Pharmacogenomic phenotypes per the canonical category-page spec: descriptive history-first lead (the debrisoquine polymorphism, Smith at St Mary's London 1977, Mahgoub 1977 PMID 71400, origin of the poor/extensive metabolizer vocabulary; Weinshilboum 1980 TPMT PMID 7191632; the genotype-to-phenotype harmonisation Caudle 2020 PMID 31647186). Phenotypes-indexed list grouped by gene (26 pages). Notes on scope, About-these-pages, references. Carries Category:Pharmacogenomics paren...
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://pharmacopedia.wiki/p/Special:Contributions/MDElliottMD"